Red blood cell alloimmunization: A new checkpoint inhibitor immune-related adverse event?

Rotin L; Ng W; Jones B; Marsell B; Cserti-Gazdewich C

doi:10.1111/trf.18409

← 뒤로

Red blood cell alloimmunization: A new checkpoint inhibitor immune-related adverse event?

0/5 보강

Transfusion 2025 Vol.65(11) p. 2211-2213

Rotin L, Ng W, Jones B, Marsell B, Cserti-Gazdewich C

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Rotin L, Ng W, et al. (2025). Red blood cell alloimmunization: A new checkpoint inhibitor immune-related adverse event?. Transfusion, 65(11), 2211-2213. https://doi.org/10.1111/trf.18409

MLA Rotin L, et al.. "Red blood cell alloimmunization: A new checkpoint inhibitor immune-related adverse event?." Transfusion, vol. 65, no. 11, 2025, pp. 2211-2213.

PMID 40960050

DOI 10.1111/trf.18409